Current Treatment Strategies and Nanoparticle-Mediated Drug Delivery Systems for Pulmonary Arterial Hypertension

There are three critical pathways for the pathogenesis and progression of pulmonary arterial hypertension (PAH): the prostacyclin (prostaglandin I(2)) (PGI(2)), nitric oxide (NO), and endothelin pathways. The current approved drugs targeting these three pathways, including prostacyclin (PGI(2)), pho...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Kazufumi, Akagi, Satoshi, Ejiri, Kentaro, Yoshida, Masashi, Miyoshi, Toru, Toh, Norihisa, Nakagawa, Koji, Takaya, Yoichi, Matsubara, Hiromi, Ito, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928621/
https://www.ncbi.nlm.nih.gov/pubmed/31771203
http://dx.doi.org/10.3390/ijms20235885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928621/
https://www.ncbi.nlm.nih.gov/pubmed/31771203
http://dx.doi.org/10.3390/ijms20235885

Ejemplares similares